Assessing the accuracy and clinical utility of GPT-4O in abnormal blood cell morphology recognition.

ABSTRACT:

Objectives

To evaluate the accuracy and clinical utility of GPT-4O in recognizing abnormal blood cell morphology, a critical component of hematologic diagnostics.

Methods

GPT-4O's blood cell morphology recognition capabilities were assessed by comparing its performance with hematologists. A total of 70 images from the Chinese National Center for Clinical Laboratories, External Quality Assessment (EQA) from 2022 to 2024 were analyzed. Two experienced hematology experts evaluated GPT-4O's recognition accuracy using a Likert scale.

Results

GPT-4O achieved an overall accuracy of 70% in blood cell morphology recognition, significantly lower than the 95.42% accuracy of hematologists (p < 0.05). For peripheral blood smears and bone marrow smears, GPT-4O's accuracy was 77.14%

SUBMITTER: Cai X 

PROVIDER: S-EPMC11536573 | biostudies-literature | 2024 Jan-Dec

REPOSITORIES: biostudies-literature